U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895329) titled 'Shiwei Anshen Granules for Chronic Insomnia' on Sept. 17.
Brief Summary: This is a multi-center, randomized, controlled clinical study inlcuding 240 subjects with chronic insomnia. The purpose of this study is to evaluate the efficacy and safety of Shiwei Anshen Granules (an Chinese herbal preparation) in patients with chronic insomnia. Eligible participants will be randomly assigned to receiving Shiwei Anshen Granules or the control group receiving placebo. All subjects will receive 2 weeks run-in period, followed 8 weeks of intervention and 2 weeks follow-up without treatment. The main outcome is the change in PSQI score before an...